Leukemia, Hairy Cell
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies (NCT05362773) | MacroGenics | 2022-07-13 |
| A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia (NCT03410875) | Memorial Sloan Kettering Cancer Center | 2018-02-09 |
| Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia (NCT01829711) | MedImmune LLC | 2013-04-29 |
| A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies (NCT00861510) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-03-05 |
Track Leukemia, Hairy Cell automatically
Every clearance here is in the API, with alerts when new ones post.